(Q48706440)

14 February 2018

title

Current concepts in the etiology, diagnosis and treatment of narcolepsy (English)

1 reference

14 February 2018

0 references

Thorpy M

1

1 reference

14 February 2018

publication date

1 January 2001

1 reference

14 February 2018

number of pages

13

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

14 February 2018

volume

2

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

5-17

1 reference

14 February 2018

Narcolepsy. Signs, symptoms, differential diagnosis, and management

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

1 reference

7 January 2021

Narcolepsy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The influence of clinical symptoms on quality of life in patients with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Psychosocial impact of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Genetic studies in the sleep disorder narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Autoradiographic studies of post-mortem human narcoleptic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Dopamine‐receptor autoradiography of human narcoleptic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Diagnostic aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The Clinical Use of the Multiple Sleep Latency Test

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

1 reference

7 January 2021

A normative study of the maintenance of wakefulness test (MWT)

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Daytime Sleepiness and Sleep Habits of Australian Workers

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The clinical diagnosis of the narcoleptic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Psychometric evaluation of the Stanford Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Compliance with stimulant medications in patients with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Selegiline in the treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Therapy with l-deprenyl (selegiline) and relation to abuse liability.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Self‐monitoring cognitive performance during sleep deprivation: effects of modafinil, d‐amphetamine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Effects of modafinil on symptomatology of human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Fluoxetine suppresses human cataplexy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Narcolepsy: a key role for hypocretins (orexins)

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

Narcolepsy and the hypocretin receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900081-2

7 January 2021

10.1016/S1389-9457(00)00081-2

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018